Centuple Global Ltd

Fri 25/09/2026,16:1:0 | BSE : CENTUPLE

₹32.910.91 (2.84%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 33.48

Previous Close

₹ 32.00

Volume

4317

Mkt Cap ( ₹ Cr)

₹ 18.00

High

₹ 33.48

Low

₹ 30.40

52 Week High

₹ 144.40

52 Week Low

₹ 28.42

Book Value Per Share

₹ 3.44

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Centuple Global Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Centuple Global Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Centuple Global - Board Meeting Outcome for Outcome Of Board Meeting

    24 Sep 2026, 2:43PM Outcome of Board Meeting
  • Centuple Global - Board Meeting Intimation for The Appointment Of A Whole-Time Director

    22 Sep 2026, 5:08PM Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/09/2026 ,inter alia, to consider and
  • Centuple Global - Reg. 34 (1) Annual Report.

    5 Sep 2026, 8:19PM Annual Report 2026
  • Centuple Global - Notice Of AGM

    5 Sep 2026, 5:49PM Notice of AGM
  • Centuple Global - Board Meeting Outcome for Outcome Of Board Meeting

    5 Sep 2026, 12:43PM Outcome of Board Meeting
  • Centuple Global - Board Meeting Intimation for Intimation Of Board Meeting

    27 Aug 2026, 4:53PM Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and
  • Centuple Global has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    26 Aug 2026, 10:10PM As of June 2026, 100.00% owned by Public. <p align=justify>
  • Centuple Global - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    26 Aug 2026, 1:01PM Compliace certificate under regulation 74 for the quarter ended June 30, 2026
  • Centuple Global - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

    14 Aug 2026, 5:35PM Resignation of statutory auditor
  • Centuple Global - Outcome Of Board Meeting

    13 Aug 2026, 6:04PM Outcome of board meeting
  • Centuple Global - Board Meeting Intimation for Intimation Of Board Meeting

    4 Aug 2026, 4:08PM Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and
  • Centuple Global - Announcement under Regulation 30 (LODR)-Resignation of Director

    13 Jul 2026, 6:26PM Resignation of Ms. Shruti gupta as Non-executive Independent Director

Key fundamentals

Evaluate the intrinsic value of Centuple Global Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 8.8003 0.5582 0.5327 0.6499 0.581
Liabilities 8.8003 0.5582 0.5327 0.6499 0.581
Equity 5.4683 5.4683 5.4683 5.4683 5.4683
Gross Profit 2.2838 0.0545 0.0287 -0.0793 -0.0214
Net Profit 1.5073 0.0254 0.0302 -0.0785 -0.0365
Cash From Operating Activities -28.0128 0.1938 -0.0163 0.0137 -0.4999
NPM(%) 0.26 5.08 2.67 -6.77 -1.81
Revenue 573.8092 0.5 1.13 1.1601 2.0111
Expenses 571.5254 0.4455 1.1012 1.2394 2.0325
ROE(%) 80.09 1.34 1.6 -4.17 -1.94

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Centuple Global Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 878.15 0.90 22.10 18.78 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 115.60 2.03 1643.86 68.44 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 12.85 -3.02 0.00 142.11 -39.50 0.00
Astec Lifesciences Ltd 737.05 1.25 0.00 73.33 -363.14 0.00

Company Info

Rubra Medicaments Limited was incorporated on 27th September, 1991 as a Private Limited Company under the Companies Act, 1956, in the name of Rubra Medicaments Private Limited. The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Rubra Medicaments Limited with effect from 2nd December, 1994. The Company's existing factory for manufacture of pharmaceutical formulations is located at Plot.No.109/3, IDA, Phase-II, Cherlapally, R.R.District (A.P) with an installed capacity as under: Tablets - 339.60 lacs nos. Capsules - 90.00 lacs nos. The Company has started operations from March' 1994 and presently manufactures antimalarial, antispasmodic, antianelgesic, antiasthamatic and antibiotics formulations, in tablets and capsule form. The Company also manufactures generic and calcium tablets. The Company now proposes to expand its existing capacity for tablets and capsules and also manufacture Anti Rheumatic Drug, Analgesic and Antipyritic drugs, Antipeptic ulcerant Drugs, Antianthraitic (Tropical Cream), Anti-infective (Skin Preparation), Nutrition supplement (Aur. Iron preparation) formulations. 2010 -Registered Office of the Company has been shifted From 109/3, IDA Phase II, Sector II, Lane 6, Cherlapally, Hyderabad - 500051 To 4-1-896, Shop No.32, Sri Rama Towers, Boggulkunta, Tilak Road, Hyderabad -500001. 2011 -Registered Office of the Company has been shifted From 4-1-896, Shop no: 32, Sri Rama Towers, Boggulkupta, Tilak Road, Hyderabad, Andhra Pradesh To 1-18-117/4, Police Lane, GunBazar Begumpet, Hyderabad, Andhra Pradesh - 500003. 2016 - The Company has shifted Registered office to Rubra Medicaments Limited 28, Level 1, am@10, MB Towers,H No. 8-2-624/A/1,Road No. 10, Banjara Hills,Hyderabad - 500034 Telangana, India 2023 -Company name has changed to Checkpoint Trends Ltd. from Rubra Medicaments Ltd..

Rubra Medicaments Limited was incorporated on 27th September, 1991 as a Private Limited Company under the Companies Act, 1956, in the name of Rubra Medicaments Private Limited. The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Rubra Medicaments Limited with effect from 2nd December, 1994. The Company's existing factory for manufacture of pharmaceutical formulations is located at Plot.No.109/3, IDA, Phase-II, Cherlapally, R.R.District (A.P) with an installed capacity as under: Tablets - 339.60 lacs nos. Capsules - 90.00 lacs nos. The Company has started operations from March' 1994 and presently manufactures antimalarial, antispasmodic, antianelgesic, antiasthamatic and antibiotics formulations, in tablets and capsule form. The Company also manufactures generic and calcium tablets. The Company now proposes to expand its existing capacity for tablets and capsules and also manufacture Anti Rheumatic Drug, Analgesic and Antipyritic drugs, Antipeptic ulcerant Drugs, Antianthraitic (Tropical Cream), Anti-infective (Skin Preparation), Nutrition supplement (Aur. Iron preparation) formulations. 2010 -Registered Office of the Company has been shifted From 109/3, IDA Phase II, Sector II, Lane 6, Cherlapally, Hyderabad - 500051 To 4-1-896, Shop No.32, Sri Rama Towers, Boggulkunta, Tilak Road, Hyderabad -500001. 2011 -Registered Office of the Company has been shifted From 4-1-896, Shop no: 32, Sri Rama Towers, Boggulkupta, Tilak Road, Hyderabad, Andhra Pradesh To 1-18-117/4, Police Lane, GunBazar Begumpet, Hyderabad, Andhra Pradesh - 500003. 2016 - The Company has shifted Registered office to Rubra Medicaments Limited 28, Level 1, am@10, MB Towers,H No. 8-2-624/A/1,Road No. 10, Banjara Hills,Hyderabad - 500034 Telangana, India 2023 -Company name has changed to Checkpoint Trends Ltd. from Rubra Medicaments Ltd..

Parent Organisation

Centuple Global Ltd.

Founded

27/09/1991

Managing Director

Mr.Sunil Khandalwal

NSE Symbol

FAQ